ADIL
Price
$0.57
Change
-$0.09 (-13.64%)
Updated
Jun 6 closing price
Capitalization
5.2M
JAGX
Price
$4.06
Change
+$0.16 (+4.10%)
Updated
Jun 6 closing price
Capitalization
4.97M
Interact to see
Advertisement

ADIL vs JAGX

Header iconADIL vs JAGX Comparison
Open Charts ADIL vs JAGXBanner chart's image
Adial Pharmaceuticals
Price$0.57
Change-$0.09 (-13.64%)
Volume$829.83K
Capitalization5.2M
Jaguar Health
Price$4.06
Change+$0.16 (+4.10%)
Volume$65.32K
Capitalization4.97M
ADIL vs JAGX Comparison Chart
Loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADIL vs. JAGX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADIL is a StrongBuy and JAGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ADIL: $0.68 vs. JAGX: $4.52)
Brand notoriety: ADIL and JAGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADIL: 9% vs. JAGX: 31%
Market capitalization -- ADIL: $5.2M vs. JAGX: $4.97M
ADIL [@Biotechnology] is valued at $5.2M. JAGX’s [@Biotechnology] market capitalization is $4.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADIL’s FA Score shows that 0 FA rating(s) are green whileJAGX’s FA Score has 0 green FA rating(s).

  • ADIL’s FA Score: 0 green, 5 red.
  • JAGX’s FA Score: 0 green, 5 red.
According to our system of comparison, ADIL is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADIL’s TA Score shows that 5 TA indicator(s) are bullish while JAGX’s TA Score has 3 bullish TA indicator(s).

  • ADIL’s TA Score: 5 bullish, 3 bearish.
  • JAGX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ADIL is a better buy in the short-term than JAGX.

Price Growth

ADIL (@Biotechnology) experienced а -4.47% price change this week, while JAGX (@Biotechnology) price change was +6.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADIL($5.2M) and JAGX($4.97M) have the same market capitalization . ADIL YTD gains are higher at: -32.673 vs. JAGX (-82.099). JAGX has more cash in the bank: 13.3M vs. ADIL (3.75M). ADIL has less debt than JAGX: ADIL (194K) vs JAGX (34.3M).
ADILJAGXADIL / JAGX
Capitalization5.2M4.97M105%
EBITDA-8.28MN/A-
Gain YTD-32.673-82.09940%
P/E RatioN/A0.01-
Revenue0N/A-
Total Cash3.75M13.3M28%
Total Debt194K34.3M1%
FUNDAMENTALS RATINGS
ADIL vs JAGX: Fundamental Ratings
ADIL
JAGX
OUTLOOK RATING
1..100
256
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8498
P/E GROWTH RATING
1..100
55100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADIL's Valuation (35) in the Pharmaceuticals Major industry is in the same range as JAGX (36) in the Pharmaceuticals Generic industry. This means that ADIL’s stock grew similarly to JAGX’s over the last 12 months.

ADIL's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as JAGX (100) in the Pharmaceuticals Generic industry. This means that ADIL’s stock grew similarly to JAGX’s over the last 12 months.

ADIL's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as JAGX (100) in the Pharmaceuticals Generic industry. This means that ADIL’s stock grew similarly to JAGX’s over the last 12 months.

ADIL's Price Growth Rating (84) in the Pharmaceuticals Major industry is in the same range as JAGX (98) in the Pharmaceuticals Generic industry. This means that ADIL’s stock grew similarly to JAGX’s over the last 12 months.

ADIL's P/E Growth Rating (55) in the Pharmaceuticals Major industry is somewhat better than the same rating for JAGX (100) in the Pharmaceuticals Generic industry. This means that ADIL’s stock grew somewhat faster than JAGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADILJAGX
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
85%
Momentum
ODDS (%)
Bullish Trend 12 days ago
87%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bullish Trend 12 days ago
89%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
Bullish Trend about 1 month ago
83%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ADIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with VANI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
+1.49%
VANI - ADIL
37%
Loosely correlated
N/A
CLYM - ADIL
34%
Loosely correlated
+6.84%
GDTC - ADIL
30%
Poorly correlated
-3.08%
VTVT - ADIL
28%
Poorly correlated
+4.05%
JAGX - ADIL
26%
Poorly correlated
+2.49%
More

JAGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAGX has been closely correlated with WINT. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if JAGX jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
+2.49%
WINT - JAGX
90%
Closely correlated
+5.12%
CDTX - JAGX
90%
Closely correlated
-5.46%
NCNA - JAGX
89%
Closely correlated
-3.85%
SNPX - JAGX
89%
Closely correlated
-10.74%
RNAC - JAGX
89%
Closely correlated
+3.65%
More